Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology

被引:531
作者
Harizi, Hed [1 ]
Corcuff, Jean-Benoit [1 ]
Gualde, Norbert [1 ]
机构
[1] Univ Bordeaux, CNRS, UMR 5540, F-33076 Bordeaux, France
关键词
D O I
10.1016/j.molmed.2008.08.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Arachidonic acid (AA)-derived eicosanoids belong to a complex family of lipid mediators that regulate a wide variety of physiological responses and pathological processes. They are produced by various cell types through distinct enzymatic pathways and act on target cells via specific G-protein-coupled receptors. Although originally recognized for their capacity to elicit biological responses such as vascular homeostasis, protection of the gastric mucosa and platelet aggregation, eicosanoids are now understood to regulate immunopathological processes ranging from inflammatory responses to chronic tissue remodelling, cancer, asthma, rheumatoid arthritis and autoimmune disorders. Here, we review the major properties of eicosanoids and their expanding roles in biology and medicine.
引用
收藏
页码:461 / 469
页数:9
相关论文
共 103 条
[1]
NSAIDs and breast cancer: a possible prevention and treatment strategy [J].
Agrawal, A. ;
Fentiman, I. S. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (03) :444-449
[2]
Akaogi Jun, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P383
[3]
Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity [J].
Aliberti, J ;
Hieny, S ;
Sousa, CRE ;
Serhan, CN ;
Sher, A .
NATURE IMMUNOLOGY, 2002, 3 (01) :76-82
[4]
Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions [J].
Avis, I ;
Hong, SH ;
Martínez, A ;
Moody, T ;
Choi, YH ;
Trepel, J ;
Das, R ;
Jett, M ;
Mulshine, JL .
FASEB JOURNAL, 2001, 15 (09) :2007-+
[5]
Leukotriene receptors:: Crucial components in vascular inflammation [J].
Back, Magnus .
THESCIENTIFICWORLDJOURNAL, 2007, 7 :1422-1439
[6]
Novel strategies for the treatment of lung cancer: Modulation of eicosanoids [J].
Backlund, Michael G. ;
Amann, Joseph M. ;
Johnson, David H. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) :825-827
[7]
Dendritic cells as therapeutic vaccines against cancer [J].
Banchereau, J ;
Palucka, AK .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (04) :296-306
[8]
CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: Implications for adjuvant activity and antibody production [J].
Bernard, Matthew P. ;
Phipps, Richard P. .
CLINICAL IMMUNOLOGY, 2007, 125 (02) :138-148
[9]
Celecoxib for the prevention of sporadic colorectal adenomas [J].
Bertagnolli, Monica M. ;
Eagle, Craig J. ;
Zauber, Ann G. ;
Redston, Mark ;
Solomon, Scott D. ;
Kim, KyungMann ;
Tang, Jie ;
Rosenstein, Rebecca B. ;
Wittes, Janet ;
Corle, Donald ;
Hess, Timothy M. ;
Woloj, G. Mabel ;
Boisserie, Frederic ;
Anderson, William F. ;
Viner, Jaye L. ;
Bagheri, Donya ;
Burn, John ;
Chung, Daniel C. ;
Dewar, Thomas ;
Foley, T. Raymond ;
Hoffman, Neville ;
Macrae, Finlay ;
Pruitt, Ronald E. ;
Saltzman, John R. ;
Salzberg, Bruce ;
Sylwestrowicz, Thomas ;
Gordon, Gary B. ;
Hawk, Ernest T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :873-884
[10]
Nuclear localization of prostaglandin E2 receptors [J].
Bhattacharya, M ;
Peri, KG ;
Almazan, G ;
Ribeiro-Da-Silva, A ;
Shichi, H ;
Durocher, Y ;
Abramovitz, M ;
Hou, X ;
Varma, DR ;
Chemtob, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15792-15797